[go: up one dir, main page]

WO2003027139A3 - Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire - Google Patents

Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire Download PDF

Info

Publication number
WO2003027139A3
WO2003027139A3 PCT/CA2002/001443 CA0201443W WO03027139A3 WO 2003027139 A3 WO2003027139 A3 WO 2003027139A3 CA 0201443 W CA0201443 W CA 0201443W WO 03027139 A3 WO03027139 A3 WO 03027139A3
Authority
WO
WIPO (PCT)
Prior art keywords
purified polypeptides
polypeptides involved
novel purified
membrane biosynthesis
biosynthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CA2002/001443
Other languages
English (en)
Other versions
WO2003027139A2 (fr
Inventor
Aled Edwards
Akil Dharamsi
Masoud Vedadi
Muhammad Zahoor Alam
Donald Awrey
Bryan Beattie
Veronica Canadien
Megan Domagala
Simon Houston
Dhushy Kanagarajah
Qin Li
Kamran Mansoury
Merry-Lynn Mcdonald
Sasha Necakov
Ivy Ng
Benjamin Pinder
Bay Sheldrick
Francois Vallee
Cristina Viola
Olga Wrezel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affinium Pharmaceuticals Inc
Original Assignee
Affinium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affinium Pharmaceuticals Inc filed Critical Affinium Pharmaceuticals Inc
Priority to AU2002328231A priority Critical patent/AU2002328231A1/en
Publication of WO2003027139A2 publication Critical patent/WO2003027139A2/fr
Publication of WO2003027139A3 publication Critical patent/WO2003027139A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La présente invention concerne des polypeptides constituant des cibles pour des bactéries pathogènes. L'invention se rapporte également à des caractéristiques biochimiques et biophysiques desdits polypeptides.
PCT/CA2002/001443 2001-09-24 2002-09-24 Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire Ceased WO2003027139A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002328231A AU2002328231A1 (en) 2001-09-24 2002-09-24 Novel purified polypeptides involved in membrane biosynthesis

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US32444901P 2001-09-24 2001-09-24
US32450401P 2001-09-24 2001-09-24
US60/324,504 2001-09-24
US60/324,449 2001-09-24
US32626901P 2001-10-01 2001-10-01
US60/326,269 2001-10-01
US32688701P 2001-10-03 2001-10-03
US60/326,887 2001-10-03
US33956001P 2001-10-24 2001-10-24
US60/339,560 2001-10-24
US33747101P 2001-10-25 2001-10-25
US60/337,471 2001-10-25
US34000001P 2001-10-26 2001-10-26
US34002701P 2001-10-26 2001-10-26
US34000201P 2001-10-26 2001-10-26
US60/340,000 2001-10-26
US60/340,002 2001-10-26
US60/340,027 2001-10-26
US34176701P 2001-12-18 2001-12-18
US60/341,767 2001-12-18
US34430701P 2001-12-21 2001-12-21
US60/344,307 2001-12-21
US34394601P 2001-12-27 2001-12-27
US60/343,946 2001-12-27

Publications (2)

Publication Number Publication Date
WO2003027139A2 WO2003027139A2 (fr) 2003-04-03
WO2003027139A3 true WO2003027139A3 (fr) 2004-02-19

Family

ID=27583840

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2002/001443 Ceased WO2003027139A2 (fr) 2001-09-24 2002-09-24 Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire

Country Status (2)

Country Link
AU (1) AU2002328231A1 (fr)
WO (1) WO2003027139A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2532024A1 (fr) 2003-07-11 2005-01-20 Affinium Pharmaceuticals, Inc. Nouveaux polypeptides purifies provenant du staphylocoque dore
CN113968900B (zh) * 2020-07-23 2023-07-25 中元汇吉生物技术股份有限公司 一种纯化C1q蛋白的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001073436A1 (fr) * 2000-03-28 2001-10-04 Wyeth Solution et structures cristallines de zipa et de complexe de zipa ainsi que leurs utilisations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001073436A1 (fr) * 2000-03-28 2001-10-04 Wyeth Solution et structures cristallines de zipa et de complexe de zipa ainsi que leurs utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 8 March 1994 (1994-03-08), XP002253174, Database accession no. U06462 *
LÖWE J: "Crystal structure Determination of FstZ from Methanococcus jannaschii", JOURNAL OF STRUCTURAL BIOLOGY, VOL. 124, PAGE(S) 235-243, 1998, ISSN: 1047-8477, XP001153693 *
YAN K ET AL: "A CONSERVED RESIDUE AT THE EXTREME C-TERMINUS OF FTSZ IS CRITICAL FOR THE FTSA-FTSZ INTERACTION IN STAPHYLOCOCCUS AUREUS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, VOL. 270, NR. 2, PAGE(S) 387-392, ISSN: 0006-291X, XP000952773 *

Also Published As

Publication number Publication date
WO2003027139A2 (fr) 2003-04-03
AU2002328231A1 (en) 2003-04-07

Similar Documents

Publication Publication Date Title
AU4815197A (en) Tetraphosphonate bicyclic trisanhydrides
WO2004041854A3 (fr) Nouveaux polypeptides bacteriens essentiels
AUPP589598A0 (en) Novel peptides
WO2003087353A3 (fr) Nouveaux polypeptides purifies impliques dans la biogenese membranaire
WO2006028561A3 (fr) Nouveaux polypeptides fabi purifies issus de fransicella tularensis
WO2003044185A3 (fr) Nouveaux polypeptides purifies iimpliques dans un metabolisme general
WO2003027139A3 (fr) Nouveaux polypeptides purifiees impliques dans la biosynthese membranaire
WO2003025007A3 (fr) Nouveaux polypeptides purifies impliques dans la biosynthese membranaire
AU1183200A (en) Novel gene encoding brain-specific membrane protein
WO2003083099A3 (fr) Nouveaux polypeptides purifies impliques dans la synthese et la modification des proteines
WO2003102190A3 (fr) Nouveaux polypeptides purifies responsables de la viabilite bacterienne
WO2003025006A3 (fr) Nouveaux polypeptides purifies impliques dans le metabolisme des cofacteurs
WO2003025004A3 (fr) Polypeptides purifies intervenant dans le traitement d'acides nucleiques
AU2002362414A1 (en) Novel molecules of the hkid-1-related protein family and uses thereof
WO2003025008A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement de proteines
WO2003087145A3 (fr) Nouveaux polypeptides purifies impliques dans la detection de densite cellulaire
WO2003084986A3 (fr) Nouveaux polypeptides modifies impliques dans le metabolisme cellulaire
WO2004044189A3 (fr) Nouveaux polypeptides purifies jouant un role dans le metabolisme
WO2004058809A3 (fr) Nouveaux polypeptides bacteriens essentiels
WO2003084987A3 (fr) Nouveaux polypeptides purifies intervenant dans la synthese et la transformation de l'acide nucleique
WO2003025005A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des proteines
WO2003035858A3 (fr) Nouveaux polypeptides purifies impliques dans le traitement des acides nucleiques
WO2003045986A3 (fr) Nouveaux polypeptides purifies impliques dans le metabolisme general
WO2004081206A3 (fr) Nouveaux polypeptides codes par des genes bacteriens essentiels
WO2003097789A3 (fr) Nouveaux polypeptides purifies issus de pseudomonas aeruginosa

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP